Metastatic oesophageal cancer requires careful diagnostic evaluation to determine the extent of disease spread and guide treatment decisions. Understanding when to seek testing, what diagnostic methods doctors use, and how these tests help qualify patients for clinical trials can help patients navigate this challenging diagnosis with greater confidence.

Introduction: Who Should Undergo Diagnostics

Diagnosing metastatic oesophageal cancer begins when symptoms raise concern or when doctors need to determine if cancer has spread beyond the oesophagus. People who should consider diagnostic evaluation include those experiencing persistent difficulty swallowing, unexplained weight loss, chest pain, or worsening heartburn. These symptoms might indicate that cancer is progressing or has already spread to distant parts of the body.^[1]

The timing of diagnostic testing is crucial because oesophageal cancer tends to grow rapidly and aggressively. Unfortunately, the oesophagus is a flexible tube that stretches to accommodate food, which means tumors can grow quite large before causing noticeable symptoms. This is why many people—about half of all cases—already have metastatic disease when they first receive their diagnosis.^[5]

It’s advisable to seek diagnostic testing immediately if you notice difficulty swallowing that doesn’t improve, especially if swallowing becomes progressively harder over weeks or months. Other warning signs include coughing or hoarseness that persists, pain behind the breastbone or between the shoulder blades, vomiting or coughing up blood, or unintentional weight loss. Even if these symptoms have other causes, they warrant prompt medical evaluation to rule out serious conditions like oesophageal cancer.^[4]

People who have already been treated for earlier-stage oesophageal cancer should also undergo regular diagnostic monitoring. Cancer can return after treatment and spread to other organs. Your medical team will recommend a schedule for follow-up testing based on your individual situation and treatment history.^[2]

Classic Diagnostic Methods

When doctors suspect oesophageal cancer or need to determine if it has spread, they use a combination of examination techniques and imaging tests. The diagnostic process typically begins with simpler tests and progresses to more detailed examinations as needed.

Initial Evaluation

The diagnostic journey usually starts with a physical examination and review of your medical history. Your doctor will ask about your symptoms, when they started, and how they’ve changed over time. They’ll check for general signs of illness, look for lumps or anything unusual, and ask about your health habits and past medical conditions. This initial assessment helps guide which tests to perform next.^[7]

A chest X-ray is often one of the first imaging tests ordered. This simple test uses radiation to create pictures of the organs and bones inside your chest. While a chest X-ray cannot definitively diagnose oesophageal cancer, it may reveal abnormalities that suggest the need for further testing.^[1]

Visualization of the Oesophagus

Esophagoscopy and upper endoscopy are procedures where doctors insert a thin, flexible tube with a camera and light through your nose or mouth into your oesophagus. Esophagoscopy focuses on examining the oesophagus itself, while upper endoscopy also allows the doctor to view your stomach. These procedures let doctors see the inside lining of your oesophagus directly and identify any suspicious areas or tumors.^[1]

During these procedures, if doctors see anything concerning, they can perform a biopsy. This involves removing a very small amount of tissue using special cutting tools passed through the endoscope. The tissue sample is then sent to a laboratory where specialists examine it under a microscope to look for cancer cells. Biopsy is the only way to definitively confirm that cancer is present.^[13]

A barium swallow study is another test that examines the oesophagus using X-rays. Before the test, you drink a white liquid called barium, which coats the inside of your oesophagus. The barium makes your oesophagus easier to see on X-ray images and can reveal changes such as narrowing, blockages, or growths that might be cancerous. If the barium swallow study shows concerning findings, your doctor will typically recommend an endoscopy for closer examination.^[13]

Determining the Extent of Spread

Once doctors have diagnosed oesophageal cancer through biopsy, they perform additional tests to determine whether the cancer has spread to other parts of the body. This process is called staging. Understanding how far the cancer has spread is essential for planning treatment and estimating outlook.^[1]

A CT scan (computed tomography scan) uses X-rays and computer technology to create detailed, three-dimensional images of your body. For oesophageal cancer, CT scans can show whether the cancer has spread to nearby lymph nodes, the liver, lungs, or other organs. The test is painless, though you may need to drink a contrast liquid or receive an injection that helps certain body structures show up more clearly on the images.^[1]

Endoscopic ultrasound combines endoscopy with ultrasound technology. During this procedure, an endoscope with an ultrasound probe at its tip is passed into your oesophagus. The ultrasound uses sound waves to create images of the oesophagus wall and nearby structures. This test is particularly useful for determining how deeply the tumor has grown into the oesophageal wall and whether it has spread to nearby lymph nodes.^[1]

A PET scan (positron emission tomography) is an imaging test that can detect cancer cells throughout the body. Before the scan, you receive a small injection of a radioactive sugar solution. Cancer cells, which use more energy than normal cells, absorb more of this sugar and show up as bright spots on the scan images. PET scans are particularly helpful for finding cancer that has spread to distant organs or lymph nodes that might not be obvious on other imaging tests.^[1]

MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues inside your body. While not always necessary for oesophageal cancer, MRI may be used in specific situations to examine certain organs or tissues more closely.^[1]

Laparoscopy is a surgical procedure sometimes used for staging. The surgeon makes small incisions in your abdomen and inserts a thin tube with a camera to directly view the organs inside. This allows the surgeon to look for signs of cancer spread that might not be visible on imaging scans. Tissue samples can also be collected during this procedure for laboratory testing.^[1]

Understanding Where Oesophageal Cancer Spreads

Knowing the most common sites where oesophageal cancer spreads helps doctors focus their diagnostic efforts. The liver and lungs are the most frequent destinations for metastatic oesophageal cancer. Research shows that cancer spreads to the liver in about 23% of cases and to the lungs in about 31% of cases. Scientists believe these organs are common metastatic sites because of how they interact through the body’s blood vessel system and the rich blood supply that flows between them.^[1]

Other common sites where oesophageal cancer may spread include lymph nodes throughout the body, adrenal glands (small organs that sit on top of the kidneys), bones, and occasionally the brain. Diagnostic imaging is specifically designed to check these areas for signs of cancer spread.^[2]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or treatment combinations for oesophageal cancer. If you’re considering participating in a clinical trial, you’ll need to undergo specific diagnostic tests to determine whether you meet the eligibility criteria. These requirements help ensure that the trial can accurately measure whether the new treatment works and that participants will be safe.

Each clinical trial has its own specific requirements, but there are common diagnostic tests that most trials require. Understanding these tests can help you prepare for the possibility of trial participation and know what to expect during the qualification process.

Standard Qualification Testing

Most clinical trials for metastatic oesophageal cancer require confirmation of your diagnosis through tissue biopsy. The trial organizers often need to review the biopsy samples themselves to confirm that you have the type and stage of cancer the trial is studying. You may need to provide tissue samples from your original diagnosis, or in some cases, undergo a new biopsy if the original samples are not available or are too old.^[10]

Complete staging through imaging tests is essential for trial qualification. Clinical trials typically require recent CT scans, PET scans, or other imaging to document exactly where cancer is located in your body and how extensive the metastatic disease is. These baseline images also allow researchers to measure changes in tumor size during treatment, which helps determine if the experimental therapy is working.^[1]

Biomarker Testing

Many modern clinical trials require biomarker testing before you can participate. Biomarkers are characteristics of cancer cells that can be measured through laboratory tests. For oesophageal cancer, particularly adenocarcinoma, some important biomarkers include:

HER2 status: HER2 is a protein found on the surface of some cancer cells. Testing determines whether your tumor is HER2-positive or HER2-negative. This information is crucial because certain targeted therapies work specifically for HER2-positive cancers. Clinical trials testing these treatments require participants to have HER2-positive tumors, while trials of other therapies might specifically seek HER2-negative participants.^[10]

PD-L1 expression: PD-L1 is a protein that can be found on tumor cells and helps them hide from the immune system. Immunotherapy drugs work by blocking this protein. Some clinical trials of immunotherapy require testing to determine what percentage of your tumor cells express PD-L1. Participants may need to have a certain level of PD-L1 expression to qualify for the trial.^[10]

Microsatellite instability (MSI) and mismatch repair deficiency (dMMR): These are genetic characteristics of tumor cells that affect how well they repair DNA mistakes. Tumors with high microsatellite instability or deficient mismatch repair often respond particularly well to certain immunotherapy treatments. Clinical trials testing these treatments may specifically recruit patients with MSI-high or dMMR tumors.^[10]

Comprehensive genomic profiling examines tumor tissue to identify specific genetic mutations or abnormalities. This testing can reveal whether your tumor has changes in specific genes that might make it susceptible to targeted therapies being studied in clinical trials. Many experts now recommend comprehensive genomic profiling at diagnosis for all patients with metastatic oesophageal cancer, as it allows treatment to be customized based on the unique characteristics of your tumor.^[10]

General Health Assessment

Beyond cancer-specific tests, clinical trials require assessment of your overall health to ensure you can safely tolerate the experimental treatment. Standard laboratory tests include blood tests to check your blood cell counts, kidney function, liver function, and other measures of organ health. These tests help doctors determine whether your body is strong enough to handle the proposed treatment.^[7]

Some trials also assess your performance status—a measure of how well you’re able to carry out daily activities. This helps researchers understand your functional capacity and ensures that participants in the study are similar in their overall health status, which makes the trial results more meaningful.